Literature DB >> 15606720

Biosimilar therapeutic agents: issues with bioequivalence and immunogenicity.

H Schellekens.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15606720     DOI： 10.1111/j.1365-2362.2004.01428.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  4 in total

Review 1.  Through the looking glass: the protein science of biosimilars.

Authors:  David Goldsmith; Martin Kuhlmann; Adrian Covic
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

Review 2.  Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations.

Authors:  George Dranitsaris; Eitan Amir; Kristine Dorward
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

Review 3.  Biosimilars: recent developments.

Authors:  A Covic; M K Kuhlmann
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.370

Review 4.  Position of Scientific Oncological Societies Towards Biosimilar Antibodies.

Authors:  Bernhard Wörmann; Marianne Sinn
Journal:  Breast Care (Basel)       Date:  2019-01-15       Impact factor: 2.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.